Welcome to Sequence Card of Peptide


Details of CancerPDF entry with Sequence SEAEDASLLSFMQGYMK
Primary information
sequence IDSeq_6958
Peptide sequenceSEAEDASLLSFMQGYMK
CancerPDF_ID CancerPDF_ID308, CancerPDF_ID1758, CancerPDF_ID1763, CancerPDF_ID2981,
PMID19795908,21136997,21136997,21136997
Protein NameApolipoprotein C-III,Apolipoprotein C-III precursor (Apo-CIII),Apolipoprotein C-III precursor (Apo-CIII),Apolipoprotein C-III
UniprotKB Entry NameAPOC3_HUMAN,APOC3_HUMAN,APOC3_HUMAN,APOC3_HUMAN
FluidPlasma,Serum,Serum,Plasma
M/Z953.9285,1905.84885,1921.84377,1905.8488
Charge2,1,1,1
Mass (in Da)NA,NA,NA,NA
fdrNA,NA,NA,NA
Profiling TechniqueLC-MS,LC-MS,LC-MS,LC-MS
Peptide Identification techniqueMALDI-TOF/TOF,LC-MS-MS/MS,LC-MS-MS/MS,LC-MS-MS/MS
Quantification TechniqueLC-MRM (multiple reaction monitoring),LC-ESI-MS,LC-ESI-MS,LC-ESI-MS
Labelled/Label FreeLabelled,Label Free,Label Free,Label Free
FDRless than 7%,NA,NA,NA
CancerPDF_ID CancerPDF_ID308, CancerPDF_ID1758, CancerPDF_ID1763, CancerPDF_ID2981,
p-ValueNA,NA,NA,NA
SoftwareFlexAnalysis 3.0 and Biotools 3.0 software,MASCOT(v. 2.2.01),MASCOT(v. 2.2.01),MASCOT(v. 2.2.01)
Length17,17,17,17
Cancer TypeDuctal adenocarcinoma of the pancreas (DAP),Colorectal cancer,Colorectal cancer,Normal
DatabaseNCBI refseq Protein Database,SwissProt Database,SwissProt Database,SwissProt Database
ModificationNA,NA,Oxidation of Met,NA
Number of Patients"42 normal, 27 patients",30 patients and 30 healthy controls,30 patients and 30 healthy controls,27 healthy individuals
RegulationNA,NA,NA,NA
ValidationNA,Leave One out Cross validation,Leave One out Cross validation,Leave One out Cross validation
SensitivityNA,NA,NA,NA
SpecificityNA,NA,NA,NA
AccuracyNA,NA,NA,NA
Peptide AtlasPeptideAtlas
IEDB